-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2003. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the Federal Register. This publication implements the IOM's recommendation.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Theresa Green, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
The IOM, at the request of the Commissioner, undertook a study of the use of FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the Federal Register. However, changes to the schedule will be posted on the FDA advisory committees' Internet site located at http://www.fda.gov/oc/advisory/default.htm. The FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).
The following list announces FDA's tentatively scheduled advisory committee meetings for 2003. You may also obtain up-to-date meeting information by calling the Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area):
Start Printed Page 77794Start SignatureCommittee Name Dates of Meetings Advisory Committee 5-Digit Information Line Code OFFICE OF THE COMMISSIONER Science Board to the Food and Drug Administration April 9, November 6 12603 CENTER FOR BIOLOGICS EVALUATION AND RESEARCH Allergenic Products Advisory Committee April 8, November 18 12388 Biological Response Modifiers Advisory Committee February 27-28, June 9-10, October 9-10 12389 Blood Products Advisory Committee March 13-14, June 19-20, September 18-19, December 11-12 19516 Transmissible Spongiform Encephalopathies Advisory Committee February 20-21, July 17-18, October 30-31 12932 Vaccines and Related Biological Products Advisory Committee February 20-21, May 8-9, September 22-23, November 19-20 12391 CENTER FOR DRUG EVALUATION AND RESEARCH Advisory Committee for Pharmaceutical Science February 12-13, March 12-13, September 17, October 21-23 12539 Advisory Committee for Reproductive Health Drugs March 24-25, August 18-19, November 13-14 12537 Anesthetic and Life Support Drugs Advisory Committee June 26-27, December 11-12 12529 Anti-Infective Drugs Advisory Committee January 8-9, March 4-5, June 10-11, October 15-16 12530 Antiviral Drugs Advisory Committee April 29-30, September 19 12531 Arthritis Advisory Committee January 30-31, September 5 12532 Cardiovascular and Renal Drugs Advisory Committee January 6-7, May 29-30, September 15-16, December 11-12 12533 Dermatologic and Ophthalmic Drugs Advisory Committee March 6-7, April 15-16, July 17-18, September 10-11 12534 Drug Safety and Risk Management Advisory Committee April 24-25, September 18-19 12535 Endocrinologic and Metabolic Drugs Advisory Committee January 13-15, June 12-13, September 11-12 12536 Gastrointestinal Drugs Advisory Committee July 17 12538 Nonprescription Drugs Advisory Committee March 6-7, June 13-14, September 16-17 12541 Start Printed Page 77795 Oncologic Drugs Advisory Committee March 3-4, March 12-13, June 10-11 12542 Peripheral and Central Nervous System Drugs Advisory Committee July 18 12543 Psychopharmacologic Drugs Advisory Committee February 27-28, September 4-5 12544 Pulmonary-Allergy Drugs Advisory Committee May 15-16, November 6-7 12545 CENTER FOR FOOD SAFETY AND APPLIED NUTRITION Food Advisory Committee February 24-26, August 18-20 10564 Biotechnology Sub-Committee March 24-25, October 15-16 10564 Dietary Supplements Sub-Committee March 27-28, September 22-23 10564 Contaminants and Natural Toxicants Sub-Committee March 6-7, September 4-5 10564 Nutrition Sub-Committee April 28-29, November 3-4 10564 Food Additives Sub-Committee June 19-20 10564 CENTER FOR DEVICES AND RADIOLOGICAL HEALTH Device Good Manufacturing Practice Advisory Committee No meetings planned 12398 Medical Devices Advisory Committee: Anesthesiology and Respiratory Therapy Devices Panel March 27-28, May 7-8, September 4-5, November 10-11 12624 Circulatory System Devices Panel February 21-22, April 24-25, June 26-27, August 28-29, October 23-24, December 11-12 12625 Clinical Chemistry and Clinical Toxicology Devices Panel February 10-11, May 19, September 8-9, December 11-12 12514 Dental Products Panel February 13-14, May 22-23, August 7-8, October 9-10 12518 Ear, Nose, and Throat Devices Panel April 8-9, June 2-3, August 4-5, October 9-10, December 4-5 12522 Gastroenterology and Urology Devices Panel January 17, April 4, July 25, October 17 12523 General and Plastic Surgery Devices Panel February 27-28, April 10-11, July 23-24, October 23-24 12519 General Hospital and Personal Use Devices Panel February 27-28, May 15-16, August 18-19, November 20-21 12520 Start Printed Page 77796 Hematology and Pathology Devices Panel March 14, June 20, October 3 12515 Immunology Devices Panel March 17-18, June 9-10, September 15-16 12516 Medical Devices Dispute Resolution Panel No meetings planned 10232 Microbiology Devices Panel March 27-28, May 5-6, August 7-8, October 16-17 12517 Molecular and Clinical Genetics Panel April 24-25, July 17-18, November 13-14 10231 Neurological Devices Panel March 6-7, June 23-24, September 18-19, December 8-9 12513 Obstetrics and Gynecology Devices Panel March 3-4, June 9-10, September 8-9, November 3-4 12524 Ophthalmic Devices Panel March 13-14, May 22-23, July 10-11, September 11-12, November 6-7 12396 Orthopaedic and Rehabilitation Devices Panel February 20-21, May 29-30, August 27-28, November 20-21 12521 Radiological Devices Panel February 4, May 20, August 12, November 18 12526 National Mammography Quality Assurance Advisory Committee April 7-8, September 8-9 12397 Technical Electronic Product Radiation Safety Standards Committee June 18 12399 CENTER FOR VETERINARY MEDICINE Veterinary Medicine Advisory Committee May 15, September 15 12548 NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and Contaminants February 10-13, June 23-25 12560 Science Advisory Board to the National Center for Toxicological Research June 3-5 12559 Dated: December 12, 2002.
William K. Hubbard,
Associate Commissioner for Policy and Planning.
[FR Doc. 02-31994 Filed 12-18-02; 8:45 am]
BILLING CODE 4160-01-S
Document Information
- Published:
- 12/19/2002
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 02-31994
- Pages:
- 77793-77796 (4 pages)
- PDF File:
- 02-31994.pdf